Trevi Therapeutics to Report Second Quarter 2026 Financial Results and Provide a Corporate Update on August 6, 2026

Go back to Trevi Therapeutics to Report Second Quarter 2026 Financial Results and Provide a Corporate Update on August 6, 2026
(NASDAQ: TRVI) Delayed: 16.82 -0.44 (2.55%)
Previous Close $17.26    52 Week High
Open $16.94    52 Week Low
Day High $17.18    P/E N/A 
Day Low $16.59    EPS
Volume 1,485,095